Dallah Healthcare Company Financials

Market Capitalization SR12.98 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	26.48
Forward PE	24.98
Price to Sales TTM	SR3.99
Price to Book MRQ	SR3.19
Enterprise to Revenue	5.04
Enterprise to EBITDA	24.91

Financial Reports as of Dec. 31, 2024

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2024-12-31
Profit Margin	15.59%
Operating Margin	15.19%
Return on Assets TTM	4.59%
Return on Equity TTM	12.96%

Income Statement

Revenue TTM	SR3,254,430,720
Revenue per Share TTM	SR33.37
Quarterly Revenue Growth	6.20%
Gross Profit TTM	SR1,136,814,976
EBITDA	SR784,429,283
Net Income to Common TTM	SR507,463,936
Diluted EPS TTM	SR4.83
Quarterly Earnings Growth YoY	30.40%

Balance Sheet

Total Cash MRQ	SR175,120,992
Total Cash per Share MRQ	SR1.73
Total Debt MRQ	SR
Total Debt to Equity MRQ	70.65
Current Ratio MRQ	0.92
Book Value per Share MRQ	SR40.13

Cash Flow

Operating Cash Flow TTM	SR478,084,405
Levered Free Cash Flow TTM	SR471,202,060

4004 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	97,589,565
Float Shares	44,177,646
Avg 10 Volume	101,799
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	47.29%
% Held by Institutions	3.83%

Stock Price Summary

Beta	0.09
Fifty Two Week Low	SR109.00
Fifty Two Week High	SR169.40
Fifty Two Week Change	-19.75%
Day 50 MA	SR120.09
Day 200 MA	SR141.08

Dividends and Splits

Forward Annual Dividend Rate	SR2.00
Forward Annual Dividend Yield	1.54%
Trailing Annual Dividend Rate	SR2.00
Trailing Annual Dividend Yield	1.54%
Payout Ratio	41.41%
Dividend Date
Ex Dividend Date	2025-06-16
Last Split Factor
Last Split Date	2020-09-14